Max Planck Institute Takes Delivery of Waters Synapt High Definition MS System
Waters Corporation (NYSE:WAT) announced today that the world-renowned Max Planck Institute is enhancing its research on neurodegenerative diseases by adding a Waters? Synapt High Definition MS? (HDMS) System to its complement of research technologies. The Institute?s Department of Cellular Biochemistry recently took delivery of its Synapt? HDMS System to study the role of proteins in causing brain-wasting diseases including Huntington?s Disease.
Waters Corporation (NYSE:WAT) announced today that the world-renowned Max Planck Institute is enhancing its researchon neurodegenerative diseases by adding a Waters Synapt High Definition MS? (HDMS) System to its complement of research technologies. The Institute?s Department of Cellular Biochemistry recently took delivery of its Synapt? HDMS System to study the role of proteins in causing brain-wasting diseasesincluding Huntington?s Disease.
?Our initial impression of the Synapt HDMS system was of a very powerful two-dimensional separation device. We wanted a system that could measurelarge intact protein complexes with high accuracy. The ability to additionally separate species by ion mobility greatly enhances the appeal of thissystem,? commented Prof. Ulrich Hartl, Director and Principal Investigator, Dr. Manajit Hayer-Hartl.
Dr. Hayer-Hartl?s research focuses on the understanding of the mechanisms by which molecular chaperones mediate protein folding and inhibit misfoldingin neurodegenerative diseases. The Synapt System will analyze the large protein complexes, and their subunit composition, that are involved in suchdiseases. Prof. Hartl and Dr. Hayer-Hartl are looking to the Synapt System to give them greater insight into protein folding, assembly, andaggregation pathways by being able to resolve, identify and characterize intermediates based on differences in conformation, something that is nearlyimpossible to do with current technology.
?We will follow folding and/or aggregation pathways in the presence or absence of chaperone systems in combination with hydrogen/deuterium exchangetechnology. The Synapt System?s Triwave technology for separating ions by their mobility will allow us to characterize our proteins of interest ingreater detail than any other mass spectrometry system currently available,? Dr. Hayer-Hartl explained.
Waters introduced the Synapt HDMS System at the American Society of Mass Spectrometry annual meeting in Seattle in June of 2006. It is the firstcommercially-available mass spectrometer to combine high-efficiency, ion mobility-based measurements and separations with a high-performanceorthogonal acceleration time-of-flight mass spectrometer.
Best of the Week: Food Analysis, Chemical Migration in Plastic Bottles, STEM Researcher of the Year
December 20th 2024Top articles published this week include the launch of our “From Lab to Table” content series, a Q&A interview about using liquid chromatography–high-resolution mass spectrometry (LC–HRMS) to assess chemical hazards in plastic bottles, and a piece recognizing Brett Paull for being named Tasmanian STEM Researcher of the Year.
Using LC-MS/MS to Measure Testosterone in Dried Blood Spots
December 19th 2024Testosterone measurements are typically performed using serum or plasma, but this presents several logistical challenges, especially for sample collection, storage, and transport. In a recently published article, Yehudah Gruenstein of the University of Miami explored key insights gained from dried blood spot assay validation for testosterone measurement.
Determination of Pharmaceuticals by Capillary HPLC-MS/MS (Dec 2024)
December 19th 2024This application note demonstrates the use of a compact portable capillary liquid chromatograph, the Axcend Focus LC, coupled to an Agilent Ultivo triple quadrupole mass spectrometer for quantitative analysis of pharmaceutical drugs in model aqueous samples.
